These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29246883)

  • 41. INTERMACS profiles of advanced heart failure: the current picture.
    Stevenson LW; Pagani FD; Young JB; Jessup M; Miller L; Kormos RL; Naftel DC; Ulisney K; Desvigne-Nickens P; Kirklin JK
    J Heart Lung Transplant; 2009 Jun; 28(6):535-41. PubMed ID: 19481012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Initial clinical experience with the HeartWare left ventricular assist system: a single-center report.
    Dell'Aquila AM; Schneider SR; Schlarb D; Redwan B; Sindermann JR; Ellger B; Stypmann J; Tjan TD; Scheld HH; Hoffmeier A
    Ann Thorac Surg; 2013 Jan; 95(1):170-7. PubMed ID: 23141906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. End of life for patients with left ventricular assist devices: Insights from INTERMACS.
    McIlvennan CK; Grady KL; Matlock DD; Helmkamp LJ; Abshire M; Allen LA
    J Heart Lung Transplant; 2019 Apr; 38(4):374-381. PubMed ID: 30642799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes in children with advanced heart failure in Japan: importance of mechanical circulatory support.
    Shimizu M; Nishinaka T; Inai K; Nakanishi T
    Heart Vessels; 2016 Jul; 31(7):1162-7. PubMed ID: 26243029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.
    Kirklin JK; Naftel DC; Kormos RL; Stevenson LW; Pagani FD; Miller MA; Baldwin JT; Young JB
    J Heart Lung Transplant; 2013 Feb; 32(2):141-56. PubMed ID: 23352390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation.
    Alba AC; Rao V; Ivanov J; Ross HJ; Delgado DH
    J Heart Lung Transplant; 2009 Aug; 28(8):827-33. PubMed ID: 19632580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictive Value of EuroSCORE II in Patients Undergoing Left Ventricular Assist Device Therapy.
    Menon AK; Mechelinck M; Unterkofler J; Goetzenich A; Autschbach R; Tewarie L; Moza A
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):475-82. PubMed ID: 26501222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. INTERMACS profiles and modifiers: Heterogeneity of patient classification and the impact of modifiers on predicting patient outcome.
    Cowger J; Shah P; Stulak J; Maltais S; Aaronson KD; Kirklin JK; Pagani FD; Salerno C
    J Heart Lung Transplant; 2016 Apr; 35(4):440-8. PubMed ID: 26683809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival results after implantation of intrapericardial third-generation centrifugal assist device: an INTERMACS-matched comparison analysis.
    Dell'Aquila AM; Schneider SR; Stypmann J; Ellger B; Redwan B; Schlarb D; Martens S; Sindermann JR
    Artif Organs; 2014 May; 38(5):383-90. PubMed ID: 24117675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implant strategies change over time and impact outcomes: insights from the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Teuteberg JJ; Stewart GC; Jessup M; Kormos RL; Sun B; Frazier OH; Naftel DC; Stevenson LW
    JACC Heart Fail; 2013 Oct; 1(5):369-78. PubMed ID: 24621968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Caregivers of Patients With Left Ventricular Assist Devices: Possible Impacts on Patients' Mortality and Interagency Registry for Mechanically Assisted Circulatory Support-Defined Morbidity Events.
    Bruce CR; Minard CG; Wilhelms LA; Abraham M; Amione-Guerra J; Pham L; Grogan SD; Trachtenberg B; Smith ML; Bruckner BA; Estep JD; Kostick KM
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28073849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New circulatory support system: heartware.
    Ozbaran M; Yagdi T; Engin C; Nalbantgil S; Ayik F; Oguz E; Engin Y; Özturk P
    Transplant Proc; 2012; 44(6):1726-8. PubMed ID: 22841255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Third INTERMACS Annual Report: the evolution of destination therapy in the United States.
    Kirklin JK; Naftel DC; Kormos RL; Stevenson LW; Pagani FD; Miller MA; Ulisney KL; Baldwin JT; Young JB
    J Heart Lung Transplant; 2011 Feb; 30(2):115-23. PubMed ID: 21215378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An Interagency Registry for Mechanically Assisted Circulatory Support Analysis.
    Shah P; Birk S; Maltais S; Stulak J; Elmi A; Pagani FD; Cowger JA
    J Heart Lung Transplant; 2017 Jun; 36(6):640-649. PubMed ID: 28087105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support.
    Kiernan MS; Grandin EW; Brinkley M; Kapur NK; Pham DT; Ruthazer R; Rame JE; Atluri P; Birati EY; Oliveira GH; Pagani FD; Kirklin JK; Naftel D; Kormos RL; Teuteberg JJ; DeNofrio D
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support. Data from the Interagency Registry for Mechanically Assisted Circulatory Support.
    Loyaga-Rendon RY; Pamboukian SV; Tallaj JA; Acharya D; Cantor R; Starling RC; Naftel D; Kirklin J
    Circ Heart Fail; 2014 Mar; 7(2):300-9. PubMed ID: 24443515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is Implantation of a Left Ventricular Assist Device in Patients With Critical or Impending Cardiogenic Shock an Absolute Contraindication? Looking Back at Our Past Experience Trying to Identify Contraindicative Risk Factors.
    Dell'Aquila AM; Schneider SR; Risso P; Welp H; Glockner DG; Alles S; Sindermann JR; Scherer M
    Artif Organs; 2015 Dec; 39(12):998-1004. PubMed ID: 26011007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Durable Mechanical Circulatory Support in Patients With Amyloid Cardiomyopathy: Insights From INTERMACS.
    Michelis KC; Zhong L; Tang WHW; Young JB; Peltz M; Drazner MH; Pandey A; Griffin J; Maurer MS; Grodin JL
    Circ Heart Fail; 2020 Dec; 13(12):e007931. PubMed ID: 33164568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.